Skip to NavigationSkip to content

Pharmafile - Manufacturing and Production News

United Therapeutics has revealed in a short announcement that, because its pulmonary arterial hypertension (PAH) therapy failed to meet its primary...
California-based biopharma firm Zogenix has been left frustrated after it received a correspondence from the FDA noting its refusal to review the...
Viiv Healthcare, the pharmaceutical firm owned by Shionogi, Pfizer and predominantly GSK, has announced its two-drug HIV regimen Dovato (...
Patients in Scotland with with advanced or unresectable hepatocellular carcinoma will now be able to access Eisai and MSD’s Lenvima (lenvatinib) as...
Johnson & Johnson has revealed plans to expand its existing Vision Care facilities at the National Technology Park in Limerick, Ireland,...
- Lyrica to be made class C drug in Northern Ireland -Feature – How I learned to stop worrying and love the placebo effect -ABPI calls for temporary...
Janssen are letting go of 49 employees due to the closure of their plant in Vacaville, California.
Novartis has revealed that its interleukin-17A (IL-17A) Cosentyx (secukinumab) has been authorised for use in China in the treatment of moderate-to...
Britain’s cost effectiveness body, the National Institute for Health and Care Excellence (NICE), has recommended Eli Lilly’s Verzenio (abemaciclib...
Teva has announced that its calcitonin gene-related peptide (CGRP) inhibitor Ajovy (fremanezumab) has been awarded marketing authorisation by the...
Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches